Preventing Adverse Incisional Outcomes at Cesarean Multicenter Trial

Experimental evidence suggests that NPWT promotes wound healing by removing exudate,
approximating the wound edges, and reducing bacterial contamination. Obesity (body mass index
[BMI] ≥30kg/m2) increases the risk for both cesarean delivery and SSIs compared to non-obese
women. The increased risk of SSIs is in part due to the increased thickness of the
subcutaneous space, allowing collection of exudates and increasing tension on wound edges,
promoting the growth of bacteria, and leading to wound infection and breakdown. Thus,
prophylactic NPWT may be particularly effective in this patient population.

During the 5-year project period, investigators from 4 collaborating perinatal centers in the
United Stated (two university and two community) will randomize 2850 obese women undergoing
cesarean delivery to receive either prophylactic negative pressure wound therapy with the
Prevena device or standard wound dressing. Women will be followed up to 30 days
postoperatively to ascertain study outcomes.

The primary outcome for the trial is superficial or deep SSI after cesarean according to the
CDC's National Healthcare Safety Network definitions. The investigators will also assess
other wound complications, adverse events potentially attributable to NPWT and
cost-effectiveness as measured by incremental cost per case of SSI prevented and per
quality-adjusted life year (QALY).

Inclusion Criteria

- Gestational age ≥23weeks

- BMI≥30 Pre-pregnancy or BMI at first prenatal visit

- Planned or unplanned cesarean delivery

Exclusion Criteria:

- Non-availability for postoperative follow-up

- Contraindication to NPWT applicable to women undergoing cesarean: Pre-existing
infection around incision site, Bleeding disorder, Therapeutic anticoagulation,
Irradiated skin, Allergy to any component of the dressing (e.g. silver, acrylic,
silicone, adhesive tape)